STOCK TITAN

Standard BioTools: MAK Capital reports 6.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Standard BioTools Inc. (LAB) common stock is the subject of an amended ownership report by MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman. Each reports beneficial ownership of 24,979,153 shares, or 6.3% of the class, as of September 30, 2026. The reporting persons report shared voting and dispositive power over all 24,979,153 shares, with zero sole voting or dispositive power. The percentage calculation uses 394,790,441 shares outstanding as of November 1, 2026.

Beneficially owned shares 24,979,153 shares Reported as of September 30, 2026, by each reporting person
Percent of class 6.3% Calculated using 24,979,153 shares beneficially owned as of September 30, 2026, and shares outstanding as of November 1, 2026
Shares outstanding 394,790,441 shares As of November 1, 2026; used in the ownership-percentage calculation
beneficial ownership regulatory
"Amount beneficially owned: 24,979,153"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared voting power: 24,979,153"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared dispositive power: 24,979,153"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LAB shares did the reporting persons beneficially own?

MAK Capital Fund LP, MAK Capital One LLC, and Michael A. Kaufman each reported beneficial ownership of 24,979,153 LAB common shares, or 6.3% of the class, as of September 30, 2026. They reported shared voting and dispositive power over 24,979,153 shares and no sole voting or dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





34385P108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The calculation is based upon 24,979,153 shares of Common Stock beneficially owned as of 09/30/2026 and a total of 394,790,441 shares of Common Stock, $0.001 par value per share, outstanding as of November 1, 2026, as reported by the Issuer on its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2026.


SCHEDULE 13G



MAK Capital Fund LP
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:11/16/2026
MAK CAPITAL ONE LLC
Signature:/s/ Michael A. Kaufman
Name/Title:Managing Member
Date:11/16/2026
Kaufman Michael A
Signature:/s/ Michael A. Kaufman
Name/Title:Michael A. Kaufman
Date:11/16/2026

Keep reading